A new targeted treatment for patients with a germline BRCA mutation: olaparib in pancreatic cancer.
Sign Up to like & getrecommendations! Published in 2020 at "Future oncology"
DOI: 10.2217/fon-2020-0334
Abstract: Pancreatic cancer has a poor prognosis. Focused efforts in the development of novel treatments of this disease have led to the approval of new combinations. Improvements in knowledge of the biology of these tumors have… read more here.
Keywords: germline brca; olaparib pancreatic; brca mutation; pancreatic cancer ... See more keywords